Skip to main content
Moores Cancer Center Moores Cancer Center
  1. HOME
  2. About
  3. Centers and Labs
  4. Howell Lab
  5. Selected Publications

Selected Publications

Tsai C.Y., Sun, S., Zhang, H., Local, A., Su, Y., Gross, L.A., Rice, W.G., Howell, S.B., APTO-253 Is a New Addition to the Repertoire of Drugs that Can Exploit DNA BRCA1/2 Deficiency. Mol Cancer Ther. 17:1167-1176, 2018  doi: 10.1158/1535-7163.MCT-17-0834.   PMID: 29626126

Local, A., Zhang, H., Benbatoul, K.D., Folger., P., Sheng, X., Tsai, C.Y., Howell, S.B., Rice, W.G.,  APTO-253 Stabilizes G-quadruplex DNA, Inhibits MYC Expression, and Induces DNA  damage in Acute Myeloid Leukemia Cells. Mol Cancer Ther. 17:1177-1186, 2018. doi: 10.1158/1535-7163.MCT-17-1209.

Lee, S., Jun, J., Kim, W.J., Tamayo, P, Howell, S.B., WNT Signaling Driven by R-spondin 1 and LGR6 in High-grade Serous Ovarian Cancer, Anticancer Res. 40: 6017 – 6028, 2020. doi: 10.21873/anticanres.14623

Yu, S., Mulero, M.C., Chen, W., Shang, X.,  Tian, S., Watanabe, J., Watanabe, A., Vorberg, T., Wong, C., Gately, D.,  and Howell, S.B.,  Therapeutic targeting of tumor cells rich in LGR stem cell receptors, Biocongugate Chem. 32: 376–384, 2021

 Sonowal, H., Zhang, H., Rice, W.R., Howell, S.B., Luxeptinib Disables NLRP3 Inflammasome-Mediated IL-1β release and Pathways Required for Secretion of Inflammatory Cytokines IL-6 and TNFα, Biochem Pharmacol, 195:114861, 20222.

Rice, W.R., Howell, S.B.,  Zhang, H., Rastgoo, N.,  Local, A., Kurtz, S.E., Lo, P.,  Bottomly, D., Wilmot, B, McWeeney, S.K., Druker, B/J., Tyner, J.W., Luxeptinib (CG-806) targets FLT3 and clusters of kinases operative in acute myeloid leukemia, Mol Cancer Ther, 21:1125-1135, 2022, doi: 10.1158/1535-7163.MCT-21-083

Wenzel AT, Champa D, Venkatesh H, Sun S, Tsai C-Y, Mesirov JP, Bui JD, Howell SB, Harismendy O. Single-cell characterization of step-wise acquisition of carboplatin resistance in ovarian cancer, NPJ Syst Biol Appl 8:20;  doi: 10.1038/s41540-022-00230-z.

Wong, C.,  Mulero, M. C., Barth, E.I, Wang, K., Gately, D., Shang, X., Tikle. S., Rice, C., Howell, S.B., Exploiting the receptor-binding domains of RSPO1 to target LGR5-expressing stem cells in ovarian cancer, J. Pharm. Expt., in press, Feb 2023

Sonowal, H., Rice, W.G., Howell, S.B.,  Luxeptinib interferes with LYN-mediated activation of SYK and modulates BCR signaling in lymphoma, PLOS One, in press, Feb 2023